Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03593408 · ClinicalTrials.gov registry record
Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support
A clinical trial of Drug Effect, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT03593408: Recruiting study of Drug Effect, sponsored by Boston Children's Hospital.
NCT03593408 is a study of Drug Effect that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03593408, a study of Drug Effect, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.
Conditions Studied
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Morphine
- DRUG Fentanyl
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2026-12-01 |
What NCT03593408 shows while recruiting
NCT03593408 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Drug Effect appearing as the primary indexed condition, and to 4 interventions - of which Midazolam is the first listed.
NCT03593408 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03593408 about?
NCT03593408 is a clinical study titled "Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support". This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.
What is the current status of trial NCT03593408?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2019-02-08. Estimated completion is 2026-12-01.
What conditions does trial NCT03593408 study?
This clinical trial studies the following conditions: Drug Effect.
What interventions are being tested in trial NCT03593408?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Morphine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT03593408?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03593408 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Effect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI